Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00466349 · ClinicalTrials.gov registry record
International SMA Patient Registry
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT00466349: Completed study, sponsored by Indiana University.
NCT00466349 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00466349 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
This is a registry of individuals affected by Spinal Muscular Atrophy (SMA) and/or family members of individuals affected by SMA. The purpose of the registry is to allow researchers studying the biological basis of SMA and potential therapies in SMA access to individuals interested in participating in research and/or experimental therapies. The International SMA Patient Registry is supported by CureSMA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 1986-05 |
| Est. Completion | 2018-01 |
What the finished NCT00466349 record still lists
NCT00466349 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00466349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00466349 about?
NCT00466349 is a clinical study titled "International SMA Patient Registry". This is a registry of individuals affected by Spinal Muscular Atrophy (SMA) and/or family members of individuals affected by SMA. The purpose of the registry is to allow researchers studying the biological basis of SMA and potential therapies in SMA access to individuals interested in participating ...
What is the current status of trial NCT00466349?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 1986-05. Estimated completion is 2018-01.
Who is sponsoring clinical trial NCT00466349?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia